Concepedia

Publication | Open Access

Efficacy of Glecaprevir/Pibrentasvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2, 4, 5, or 6 Infection Without Cirrhosis

221

Citations

18

References

2017

Year

References

YearCitations

Page 1